FDA product code QIC: Hiv-1 Genotyping Assay Using Ngs Technology
QIC is the FDA product code for hiv-1 genotyping assay using ngs technology. It is a Class II device, regulated under 21 CFR 866.3955 and reviewed by the Microbiology panel. Devices under QIC reach the market by 510(k); FDA lists no cleared 510(k)s for it.
Definition
The human immunodeficiency virus (HIV) drug resistance genotyping assay using next generation sequencing (NGS) technology is a prescription in vitro diagnostic device intended for use in detecting HIV genomic mutations that confer resistance to specific anti-retroviral drugs. The device is intended to be used as an aid in monitoring and treating HIV infection.
Classification
| Field | Value |
|---|---|
| Device name | Hiv-1 Genotyping Assay Using Ngs Technology |
| Device class | Class II |
| Regulation | 21 CFR 866.3955 |
| Review panel | MI — Microbiology |
| Medical specialty | Medical Genetics |
| Premarket route | 510(k) |
Recalls for QIC devices
FDA recall records list no recalls for product code QIC.
Frequently asked questions
What is FDA product code QIC?
QIC is the FDA product code for hiv-1 genotyping assay using ngs technology. It is a Class II device, regulated under 21 CFR 866.3955 and reviewed by the Microbiology panel.
What device class is QIC?
Class II, regulation 21 CFR 866.3955. Typical premarket route: 510(k).
Next steps
- Run an FDA pathway report with predicate devices for product code QIC
- Run a recall and safety report across every QIC manufacturer
- Watch product code QIC for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times